ROYCE & ASSOCIATES LP - HARMONY BIOSCIENCES HLDGS IN ownership

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q3 2023$9,187,037
+18.9%
280,349
+27.7%
0.09%
+25.3%
Q2 2023$7,726,985
-28.8%
219,579
-33.9%
0.08%
-31.2%
Q1 2023$10,850,542
-14.5%
332,329
+44.3%
0.11%
-18.0%
Q4 2022$12,687,877
-3.2%
230,270
-22.2%
0.13%
-10.1%
Q3 2022$13,110,000
+0.2%
296,010
+10.4%
0.15%
+9.6%
Q2 2022$13,080,000
+5.1%
268,197
+4.8%
0.14%
+27.4%
Q1 2022$12,445,000
+33.2%
255,807
+16.8%
0.11%
+51.4%
Q4 2021$9,342,000
+6.2%
219,084
-4.5%
0.07%
+6.1%
Q3 2021$8,793,000
+143.2%
229,390
+79.1%
0.07%
+164.0%
Q2 2021$3,615,000128,0500.02%
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$367,614,94198.94%
Nan Fung Group Holdings Ltd 368,665$12,081,1529.78%
venBio Partners LLC 1,035,396$33,929,9279.62%
Vivo Capital, LLC 2,606,247$85,406,7149.36%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 314,500$10,306,1653.47%
AlphaCentric Advisors LLC 122,000$3,997,9402.27%
ASHFORD CAPITAL MANAGEMENT INC 434,148$14,227,0302.09%
Altium Capital Management LP 117,000$3,834,0902.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 595,490$19,514,2071.90%
TANG CAPITAL MANAGEMENT LLC 271,200$8,887,2241.25%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders